Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
3.450
-0.210 (-5.74%)
Mar 13, 2025, 11:17 AM EDT - Market open
Relay Therapeutics Stock Forecast
RLAY's stock price has decreased by -61.47% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Relay Therapeutics stock have an average target of 19.33, with a low estimate of 16 and a high estimate of 24. The average target predicts an increase of 460.29% from the current stock price of 3.45.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Relay Therapeutics stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 3 | 3 | 4 | 4 | 4 | 4 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +363.77% | Mar 7, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $20 → $18 | Strong Buy | Maintains | $20 → $18 | +421.74% | Feb 27, 2025 |
| Stifel | Stifel | Strong Buy Maintains $27 → $23 | Strong Buy | Maintains | $27 → $23 | +566.67% | Feb 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +363.77% | Jan 14, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $21 | Buy | Reiterates | $21 | +508.70% | Dec 12, 2024 |
Financial Forecast
Revenue This Year
3.59M
from 10.01M
Decreased by -64.17%
Revenue Next Year
23.10M
from 3.59M
Increased by 544.28%
EPS This Year
-2.69
from -2.36
EPS Next Year
-2.61
from -2.69
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 26.3M | 81.1M | 86.8M | ||
| Avg | 3.6M | 23.1M | 22.4M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 162.3% | 2,160.8% | 275.8% | ||
| Avg | -64.2% | 544.3% | -3.0% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -2.34 | -1.98 | -2.12 | ||
| Avg | -2.69 | -2.61 | -2.53 | ||
| Low | -3.25 | -3.01 | -2.78 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.